Index S&P 500
P/E 15.90
EPS (ttm) 22.28
Insider Own 28.06%
Shs Outstand 265.54M
Perf Week -0.85%
Market Cap 89.24B
Forward P/E 14.35
EPS next Y 24.68
Insider Trans -0.05%
Shs Float 182.21M
Perf Month -8.54%
Income 5.93B
PEG 1.32
EPS next Q 6.20
Inst Own 66.42%
Short Float 1.57%
Perf Quarter -2.00%
Sales 69.62B
P/S 1.28
EPS this Y 15.89%
Inst Trans -0.20%
Short Ratio 2.34
Perf Half Y 8.42%
Book/sh -8.57
P/B -
EPS next Y 12.03%
ROA 10.40%
Short Interest 2.86M
Perf Year 52.95%
Cash/sh 11.84
P/C 29.92
EPS next 5Y 12.00%
ROE -
52W Range 226.48 - 417.14
Perf YTD 30.84%
Dividend Est. 2.63 (0.74%)
P/FCF 15.18
EPS past 5Y 12.21%
ROI 15.59%
52W High -15.10%
Beta 1.67
Dividend TTM 2.58 (0.73%)
Quick Ratio 1.00
Sales past 5Y 6.95%
Gross Margin 15.08%
52W Low 56.38%
ATR (14) 10.06
Dividend Ex-Date Dec 13, 2024
Current Ratio 1.12
EPS Y/Y TTM 8.96%
Oper. Margin 15.08%
RSI (14) 36.08
Volatility 2.56% 2.28%
Employees 310000
Debt/Eq -
Sales Y/Y TTM 10.23%
Profit Margin 8.52%
Recom 1.78
Target Price 409.57
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 24.72%
Payout 12.66%
Rel Volume 1.03
Prev Close 356.03
Sales Surprise -0.30%
EPS Surprise -1.16%
Sales Q/Q 7.86%
Earnings Oct 25 BMO
Avg Volume 1.22M
Price 354.16
SMA20 -6.83%
SMA50 -9.10%
SMA200 2.81%
Trades
Volume 1,252,655
Change -0.53%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-11-24 Initiated
KeyBanc Capital Markets
Overweight
$475
Sep-03-24 Initiated
Morgan Stanley
Equal-Weight
$427
May-30-24 Initiated
Robert W. Baird
Outperform
$396
Mar-06-24 Initiated
Barclays
Overweight
$356
Jan-04-24 Downgrade
Bernstein
Outperform → Mkt Perform
$277 → $301
Dec-11-23 Downgrade
Goldman
Buy → Neutral
$271
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$304
Apr-19-23 Resumed
JP Morgan
Neutral
$257 → $283
Jul-06-22 Downgrade
BMO Capital Markets
Market Perform → Underperform
$233 → $160
Jun-17-22 Initiated
Loop Capital
Buy
$240
May-27-22 Upgrade
Bernstein
Mkt Perform → Outperform
$273 → $271
Mar-29-22 Initiated
Wells Fargo
Equal Weight
$267
Jan-10-22 Resumed
Citigroup
Buy
$274 → $306
Dec-21-21 Downgrade
JP Morgan
Overweight → Neutral
$270
Sep-27-21 Initiated
SVB Leerink
Outperform
$320
Sep-24-21 Initiated
UBS
Buy
$312
Sep-10-21 Initiated
Cowen
Outperform
$293
Aug-12-21 Downgrade
Barclays
Overweight → Equal Weight
$275 → $267
Jul-09-21 Initiated
Seaport Global Securities
Buy
$235
May-13-21 Resumed
Citigroup
Neutral
$215
Show Previous Ratings
Today 08:30AM
Nov-06-24 10:34AM
(The Wall Street Journal)
10:34AM
(The Wall Street Journal)
Nov-01-24 01:04AM
Oct-29-24 04:57AM
07:57AM
Loading…
Oct-26-24 07:57AM
03:07AM
01:06AM
(Thomson Reuters StreetEvents)
Oct-25-24 04:02PM
(Yahoo Finance Video) -8.86%
03:30PM
01:43PM
12:44PM
12:40PM
11:47AM
11:31AM
(The Wall Street Journal)
11:11AM
Loading…
11:11AM
(The Wall Street Journal)
10:32AM
09:30AM
08:55AM
08:54AM
07:51AM
(Associated Press Finance)
07:37AM
07:30AM
Oct-24-24 09:45AM
Oct-23-24 09:40AM
Oct-22-24 09:15AM
08:30AM
Oct-19-24 09:15AM
Oct-18-24 10:00AM
Oct-17-24 05:00PM
07:41AM
Loading…
07:41AM
Oct-16-24 06:26AM
06:26AM
Oct-15-24 11:30AM
(The Wall Street Journal)
Oct-05-24 09:24AM
Oct-04-24 12:10PM
Oct-02-24 05:26AM
Oct-01-24 02:07PM
Sep-28-24 01:21PM
Sep-26-24 04:00PM
Sep-24-24 04:30PM
Sep-20-24 12:00PM
10:09AM
09:30AM
Sep-18-24 04:18AM
Sep-12-24 09:50AM
Sep-09-24 09:40AM
09:30AM
Sep-04-24 09:45AM
Aug-30-24 09:40AM
Aug-28-24 03:38PM
Aug-27-24 09:30AM
Aug-25-24 02:56AM
Aug-24-24 09:30AM
Aug-22-24 11:30AM
Aug-21-24 04:00AM
Aug-20-24 12:29PM
Aug-16-24 09:45AM
09:30AM
Aug-14-24 09:40AM
Aug-12-24 05:00PM
Aug-07-24 08:22AM
Aug-05-24 09:30AM
Aug-02-24 07:57AM
Jul-31-24 09:45AM
Jul-30-24 09:00AM
01:01AM
Jul-29-24 06:25PM
09:40AM
Jul-26-24 10:31PM
Jul-25-24 05:24PM
(The Wall Street Journal)
09:50AM
09:30AM
Jul-24-24 06:01PM
09:26AM
05:08AM
(Thomson Reuters StreetEvents)
Jul-23-24 03:49PM
02:45PM
02:03PM
01:38PM
01:24PM
10:50AM
(The Wall Street Journal)
09:42AM
(Investor's Business Daily)
09:30AM
08:40AM
07:44AM
(Associated Press Finance)
07:39AM
07:30AM
Jul-22-24 09:40AM
Jul-18-24 02:55PM
Jul-16-24 10:00AM
09:00AM
(Investor's Business Daily)
Jul-15-24 01:50PM
(Investor's Business Daily)
11:40AM
Jul-14-24 09:15AM
Jul-13-24 11:00AM
Jul-12-24 09:15AM
Jul-08-24 12:10PM
Jul-02-24 06:55AM
Jun-26-24 09:40AM
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cuffe Michael S. EVP and Chief Clinical Officer Sep 10 '24 Option Exercise 145.24 22,080 3,206,899 51,758 Sep 12 05:21 PM Cuffe Michael S. EVP and Chief Clinical Officer Sep 12 '24 Sale 385.42 8,358 3,221,340 29,678 Sep 12 05:21 PM Cuffe Michael S. Officer Sep 12 '24 Proposed Sale 385.42 8,358 3,221,340 Sep 12 05:13 PM McManus Timothy M Group President Jul 31 '24 Option Exercise 77.13 7,500 578,475 30,927 Aug 02 05:21 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 29 '24 Option Exercise 145.24 8,280 1,202,587 19,598 Jul 31 05:44 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 31 '24 Sale 363.51 2,987 1,085,804 9,454 Jul 31 05:44 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 29 '24 Sale 359.92 1,864 670,891 12,441 Jul 31 05:44 PM Reiner Deborah M SVP - Mktg. & Communications Jul 29 '24 Sale 359.96 3,314 1,192,914 3,510 Jul 31 05:12 PM Whalen Kathleen M Officer Jul 31 '24 Proposed Sale 363.51 2,987 1,085,804 Jul 31 04:15 PM Wyatt Christopher F. SVP & Controller Jul 25 '24 Option Exercise 101.16 9,300 940,788 49,727 Jul 29 05:25 PM Wyatt Christopher F. SVP & Controller Jul 29 '24 Sale 360.20 4,000 1,440,782 40,449 Jul 29 05:25 PM Torres Kathryn A. SVP-Payer Contracting & Align. Jul 25 '24 Sale 355.05 1,857 659,328 17,755 Jul 29 05:18 PM Wyatt Christopher F. Officer Jul 29 '24 Proposed Sale 360.20 4,000 1,440,783 Jul 29 04:24 PM Reiner Deborah M Officer Jul 29 '24 Proposed Sale 359.96 3,314 1,192,914 Jul 29 04:18 PM Whalen Kathleen M Officer Jul 29 '24 Proposed Sale 359.92 1,864 670,891 Jul 29 04:07 PM Whalen Kathleen M SVP & Chief Ethics Officer May 17 '24 Option Exercise 112.70 4,725 532,524 14,179 May 20 05:23 PM Whalen Kathleen M SVP & Chief Ethics Officer May 16 '24 Sale 326.30 3,204 1,045,465 9,454 May 20 05:23 PM Torres Kathryn A. SVP-Payer Contracting & Align. May 15 '24 Sale 326.18 1,863 607,673 19,612 May 17 05:14 PM Sowell Joseph A III SVP; Chief Development Officer May 15 '24 Option Exercise 68.96 19,000 1,310,240 23,275 May 17 05:13 PM Foster Jon M EVP and COO May 15 '24 Option Exercise 78.21 39,465 3,086,548 61,295 May 17 05:13 PM Cuffe Michael S. EVP and Chief Clinical Officer May 09 '24 Sale 316.88 6,311 1,999,825 29,624 May 13 05:08 PM Cohen Jeffrey E. SVP-Government Relations May 09 '24 Sale 313.00 1,650 516,450 5,185 May 13 05:07 PM Cuffe Michael S. EVP and Chief Clinical Officer May 07 '24 Option Exercise 139.06 18,660 2,594,860 52,784 May 08 05:43 PM Cuffe Michael S. EVP and Chief Clinical Officer May 06 '24 Sale 309.00 1,600 494,400 34,124 May 08 05:43 PM Torres Kathryn A. SVP-Payer Contracting & Align. May 02 '24 Sale 312.00 973 303,576 22,365 May 06 06:39 PM Torres Kathryn A. SVP-Payer Contracting & Align. May 03 '24 Sale 312.00 890 277,680 21,475 May 06 06:39 PM Wasserman Chad J SVP and CIO Mar 18 '24 Option Exercise 101.16 2,100 212,436 4,020 Mar 20 05:16 PM Wasserman Chad J SVP and CIO Mar 20 '24 Sale 330.25 876 289,299 1,576 Mar 20 05:16 PM Wasserman Chad J SVP and CIO Mar 18 '24 Sale 321.97 344 110,758 2,452 Mar 20 05:16 PM Whalen Kathleen M SVP & Chief Ethics Officer Feb 09 '24 Sale 306.21 4,262 1,305,074 10,250 Feb 13 07:03 PM Torres Kathryn A. SVP-Payer Contracting & Align. Feb 06 '24 Option Exercise 173.12 2,092 362,167 21,717 Feb 08 07:13 PM Wyatt Christopher F. SVP & Controller Feb 05 '24 Sale 312.42 4,000 1,249,680 37,383 Feb 07 07:45 PM Whalen Kathleen M SVP & Chief Ethics Officer Feb 05 '24 Option Exercise 82.82 8,550 708,084 18,800 Feb 07 07:45 PM RUTHERFORD BILL B CFO and EVP Feb 02 '24 Option Exercise 69.58 19,100 1,328,978 25,469 Feb 06 06:34 PM RUTHERFORD BILL B CFO and EVP Feb 06 '24 Sale 310.63 6,000 1,863,780 8,448 Feb 06 06:34 PM Mosier Sammie S SVP & Chief Nurse Executive Feb 02 '24 Option Exercise 231.79 6,298 1,459,806 14,315 Feb 06 06:29 PM Mosier Sammie S SVP & Chief Nurse Executive Feb 05 '24 Sale 312.00 1,645 513,240 7,646 Feb 06 06:29 PM Wasserman Chad J SVP and CIO Feb 02 '24 Sale 312.04 652 203,451 290 Feb 06 06:28 PM Wyatt Christopher F. SVP & Controller Jan 31 '24 Option Exercise 96.75 11,680 1,130,093 47,759 Feb 02 06:53 PM Torres Kathryn A. SVP-Payer Contracting & Align. Feb 01 '24 Option Exercise 184.24 12,994 2,393,958 28,893 Feb 02 06:51 PM Torres Kathryn A. SVP-Payer Contracting & Align. Jan 31 '24 Sale 307.00 3,861 1,185,327 15,899 Feb 02 06:51 PM Cuffe Michael S. EVP and Chief Clinical Officer Jan 31 '24 Sale 306.79 3,200 981,734 24,929 Feb 02 06:38 PM Akdamar Erol R Group President Nov 13 '23 Option Exercise 47.97 26,825 1,286,795 26,825 Nov 15 05:37 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite